Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
J Neurol Neurosurg Psychiatry
The psychometric properties of rating scales are sample dependent and need evaluations in different samples. The Multiple Sclerosis Impact Scale (MSIS-29), a new patient based rating scale for multiple sclerosis (MS) was predominantly developed from a community based sample derived from the MS Society. A number of important patient characteristics of this sample remain unknown. The aim of the study was to evaluate five psychometric properties of the MSIS-29 in three hospital based samples: people admitted for rehabilitation, people admitted for intravenous corticosteroid treatment for MS relapses, and people with primary progressive MS.
|Title:||Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.|
|Keywords:||Adolescent, Adrenal Cortex Hormones, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Patient Admission, Psychometrics, Quality of Life, Reproducibility of Results, Sickness Impact Profile|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Brain Sciences
Archive Staff Only